Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a novel transcript classified as an antisense long non-coding RNA relative to the CWC27 gene. It is identified by Ensembl as ENSG00000304095 and does not correspond to a protein-coding gene. There is currently no characterization of its molecular function, biological impact, or disease relevance. The antisense relationship means its sequence is complementary to the CWC27 gene, which encodes a spliceosomal protein involved in mRNA splicing; however, the role of the antisense transcript itself is unknown. Based on public sources and gene databases, it is not considered a classical therapeutic target or biomarker at this time[3]. If you are seeking information on the protein-coding gene CWC27 itself (not this antisense transcript), CWC27 encodes a spliceosomal component involved in RNA splicing, with roles in retinal disease and other cellular processes[1]. However, ENSG00000304095 itself does not code for this protein and is not directly associated with these functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CWC27 (ENSG00000304095).